Freeman Chris: insider trades.
Freeman Chris reported 11 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($10.8M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Freeman Chris
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Guardant Health, Inc. (GH) | Officer · Chief Commercial Officer | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | Guardant Health, Inc. | S | 35,364 | $169.63 | 82,787 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | S | 7,365 | $168.79 | 118,151 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | S | 3,463 | $167.38 | 125,516 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | M | 28,193 | $28.37 | 128,979 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | M | 35,412 | $110.49 | 100,786 | Form 4 |
| 2026-08-10 | Guardant Health, Inc. | S | 17,413 | $170.24 | 65,374 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 1,293 | $0 | 68,515 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 1,928 | $0 | 63,029 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 1,667 | $0 | 64,696 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 2,526 | $0 | 67,222 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | F | 3,141 | $170.77 | 65,374 | Form 4 |
Questions
What stock did Freeman Chris buy or sell?
Freeman Chris reported 11 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($10.8M), across 1 company.
Is Freeman Chris the same person as other filers with this name?
This page covers SEC CIK 1871615 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/freeman-chris-1871615.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.